144 related articles for article (PubMed ID: 16138425)
21. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
[TBL] [Abstract][Full Text] [Related]
22. Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
Jobson S; Moise PA; Eskandarian R
Clin Ther; 2011 Oct; 33(10):1391-9. PubMed ID: 22015328
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.
Ribera E; Gómez-Jimenez J; Cortes E; del Valle O; Planes A; Gonzalez-Alujas T; Almirante B; Ocaña I; Pahissa A
Ann Intern Med; 1996 Dec; 125(12):969-74. PubMed ID: 8967707
[TBL] [Abstract][Full Text] [Related]
24. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study.
Nguyen CT; Gandhi T; Chenoweth C; Lassiter J; Dela Pena J; Eschenauer G; Nagel JL
J Antimicrob Chemother; 2015 Dec; 70(12):3390-6. PubMed ID: 26338049
[TBL] [Abstract][Full Text] [Related]
25. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
[TBL] [Abstract][Full Text] [Related]
26. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
[TBL] [Abstract][Full Text] [Related]
27. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
28. Methicillin-resistant Staphylococcus aureus bacteraemia in neonatal intensive care units: an analysis of 90 episodes.
Chuang YY; Huang YC; Lee CY; Lin TY; Lien R; Chou YH
Acta Paediatr; 2004 Jun; 93(6):786-90. PubMed ID: 15244228
[TBL] [Abstract][Full Text] [Related]
29. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
[TBL] [Abstract][Full Text] [Related]
30. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Rosa R; Wawrzyniak A; Sfeir M; Smith L; Abbo LM
J Hosp Med; 2016 Jan; 11(1):27-32. PubMed ID: 26381394
[TBL] [Abstract][Full Text] [Related]
31. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
[TBL] [Abstract][Full Text] [Related]
32. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
Braquet P; Alla F; Cornu C; Goehringer F; Piroth L; Chirouze C; Revest M; Lechiche C; Duval X; Le Moing V;
Clin Microbiol Infect; 2016 Nov; 22(11):948.e1-948.e7. PubMed ID: 27515395
[TBL] [Abstract][Full Text] [Related]
34. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
35. Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study.
Bai AD; Findlater A; Irfan N; Singhal N; Loeb M
Int J Antimicrob Agents; 2021 Nov; 58(5):106429. PubMed ID: 34469802
[TBL] [Abstract][Full Text] [Related]
36. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.
Bernard L; Vaudaux P; Vuagnat A; Stern R; Rohner P; Pittet D; Schrenzel J; Hoffmeyer P;
Infect Control Hosp Epidemiol; 2003 Sep; 24(9):650-4. PubMed ID: 14510246
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.
Denniston S; Riordan FA
J Infect; 2006 Dec; 53(6):387-93. PubMed ID: 16476482
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX;
BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161
[TBL] [Abstract][Full Text] [Related]
39. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
Roghmann MC
Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Legg A; Meagher N; Johnson SA; Roberts MA; Cass A; Scheetz MH; Davies J; Roberts JA; Davis JS; Tong SYC
Clin Drug Investig; 2023 Jan; 43(1):23-33. PubMed ID: 36217068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
